@moderna_tx Moderna
Moderna posts on X about in the, we are, the first, up to the most. They currently have [-------] followers and [---] posts still getting attention that total [------] engagements in the last [--] hours.
Engagements: [------] #
- [--] Week [-------] +33,471%
- [--] Month [-------] +1,009%
- [--] Months [-------] -91%
- [--] Year [---------] +0.88%
Mentions: [--] #
- [--] Week [--] +100%
- [--] Month [--] +500%
- [--] Months [--] +180%
- [--] Year [--] -51%
Followers: [-------] #
- [--] Week [-------] +0.04%
- [--] Month [-------] -0.11%
- [--] Months [-------] -0.63%
- [--] Year [-------] -1.50%
CreatorRank: [-------] #
Social Influence
Social category influence countries 12% stocks 3%
Social topic influence in the 22%, we are 16%, the first 13%, up to 8%, authorization 8%, nih 4%, data 2%, covid19 2%, cove 2%, australia 2%
Top accounts mentioned or mentioned by @ricpuglisi @klln349312 @merck @corpsman1st @andijjj @avidrio5 @boulmer5 @nejm @barda @nih @maribelrcoronel @dralfredotorre1 @chdtvlive @extranenne @slakevital @mithrl_ai @srqsmartypints @inabster @karolgr62577501 @usfda
Top Social Posts
Top posts by engagements in the last [--] hours
"Moderna and @Merck announced todaymedian five-year follow-up data from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study evaluating intismeran autogene (mRNA-4157 or V940) an investigational mRNA-based individualized neoantigen therapy (INT) in combination with KEYTRUDA(pembrolizumab) Merck's anti-PD-1 therapy in patients with high-risk melanoma (stage III/IV) following complete resection. Read more: https://feeds.issuerdirect.com/news-release.htmlnewsid=7585547225835569&symbol=MRNA https://feeds.issuerdirect.com/news-release.htmlnewsid=7585547225835569&symbol=MRNA"
X Link 2026-01-20T11:04Z 143.6K followers, 15.6K engagements
"Today we announced that the U.S. Food and Drug Administrations (FDA) Center for Biologics Evaluation and Research (CBER) has notified Moderna that it will not initiate a review of the biologics license application (BLA) for our investigational influenza vaccine mRNA-1010 and has issued a Refusal-to-File letter. Read more: https://feeds.issuerdirect.com/news-release.htmlnewsid=7346090610333866&symbol=MRNA https://feeds.issuerdirect.com/news-release.htmlnewsid=7346090610333866&symbol=MRNA"
X Link 2026-02-10T23:05Z 143.6K followers, 178.9K engagements
"Today we announced a strategic collaboration with Recordati to advance our investigational propionic acidemia therapeutic mRNA-3927 through the final stages of clinical development and upon approval global commercialization. Through this agreement Moderna will continue to lead the clinical development of mRNA-3927 through approval and Recordati will lead commercialization. Read more: https://feeds.issuerdirect.com/news-release.htmlnewsid=8361946056927408&symbol=MRNA https://feeds.issuerdirect.com/news-release.htmlnewsid=8361946056927408&symbol=MRNA"
X Link 2026-01-29T22:08Z 143.6K followers, [----] engagements
"Earlier today we announced a strategic collaboration with Recordati to advance our investigational propionic acidemia (PA) therapy mRNA-3927 through the final stages of clinical development and upon approval global commercialization. Stphane Bancel CEO sat down for an episode of IR Insights to give an overview of the partnership. Watch the episode here: https://www.modernatx.com/en-US/media-center/all-media/blogs/recordati-collaboration-globally-commercialize-investigational-propionic-acidemia-therapy"
X Link 2026-01-29T22:23Z 143.6K followers, [----] engagements
"Today we announced that the European Commission has granted marketing authorization for mNEXSPIKE (mRNA-1283) a new COVID vaccine for activeimmunization to prevent COVID-19 caused by SARS-CoV-2 in individuals aged [--] years and older. Read more: https://feeds.issuerdirect.com/news-release.htmlnewsid=8201845178897387&symbol=MRNA https://feeds.issuerdirect.com/news-release.htmlnewsid=8201845178897387&symbol=MRNA"
X Link 2026-02-17T12:06Z 143.6K followers, 14.7K engagements
"Today we reported financial results and provided business updates for the fourth quarter of [----]. Read more: https://feeds.issuerdirect.com/news-release.htmlnewsid=4757591928778639&symbol=MRNA https://feeds.issuerdirect.com/news-release.htmlnewsid=4757591928778639&symbol=MRNA"
X Link 2026-02-13T12:03Z 143.6K followers, [----] engagements
"We just announced positive interim Phase [--] data for our mRNA vaccine (mRNA-1273) against novel coronavirus. Read more: https://buff.ly/3bEUhZ9 https://buff.ly/3bEUhZ9"
X Link 2020-05-18T11:33Z 143.6K followers, [----] engagements
"We are pleased to share that as of today Friday August 21st [-----] participants have been enrolled in the COVE Phase [--] study of mRNA-1273. Find out more about the trial here: Check back next Friday evening for an updated enrollment number. https://buff.ly/2YlQI6q https://buff.ly/2YlQI6q"
X Link 2020-08-21T22:50Z 143.6K followers, [---] engagements
"We are pleased to share that as of today Friday September 4th [-----] participants have been enrolled in the COVE Phase [--] study of mRNA-1273. Find out more about the trial here: Check back next Friday evening for an updated enrollment number. https://buff.ly/2Z37O9F https://buff.ly/2Z37O9F"
X Link 2020-09-04T22:12Z 143.6K followers, [---] engagements
"While the pandemic continues Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic. Read our statement here: https://buff.ly/3ntU6qV https://buff.ly/3ntU6qV"
X Link 2020-10-08T10:48Z 143.6K followers, [---] engagements
"We just announced that we have completed case accrual for the first planned interim analysis of mRNA-1273 our mRNA vaccine against COVID-19. Read more: https://buff.ly/38AyunI https://buff.ly/38AyunI"
X Link 2020-11-11T21:16Z 143.6K followers, [---] engagements
"We just announced that mRNA-1273 our COVID-19 vaccine candidate has met its primary efficacy endpoint in the first interim analysis of the Phase [--] COVE study. Read more: https://buff.ly/3puVGK6 https://buff.ly/3puVGK6"
X Link 2020-11-16T12:00Z 143.6K followers, [----] engagements
"We just announced that the European Commission has approved an agreement to secure [--] million doses of mRNA-1273 with the option to increase their purchase to a total of up to [---] million doses. Read more: #mRNA https://buff.ly/360P3Yd https://buff.ly/360P3Yd"
X Link 2020-11-25T11:54Z 143.6K followers, [---] engagements
"We just announced that the first adolescent participants have been dosed in the Phase 2/3 study of mRNA-1273 our vaccine candidate against COVID-19 in adolescents ages [--] to less than [--]. Read more: https://buff.ly/2Iz5li6 https://buff.ly/2Iz5li6"
X Link 2020-12-10T12:04Z 143.6K followers, [---] engagements
"We just announced the U.S. gov't has exercised the 1st option for an additional [---] million doses of our COVID-19 vaccine candidate which will be delivered in Q2 [----]. Read more: https://buff.ly/37ag2kD https://buff.ly/37ag2kD"
X Link 2020-12-11T21:37Z 143.6K followers, [---] engagements
"We just confirmed that the @US_FDA VRBPAC recommended that the FDA grant an Emergency Use Authorization for our COVID-19 vaccine candidate mRNA-1273. [--] VRBPAC members recommended for EUA [--] members voted against and [--] abstained. Read more: https://buff.ly/2K52KNR https://buff.ly/2K52KNR"
X Link 2020-12-17T22:41Z 143.6K followers, [----] engagements
"Please see Emergency Use Authorization (EUA) Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) and Full EUA Prescribing Information available at https://buff.ly/3aoxkfQ https://buff.ly/3aoxkfQ"
X Link 2020-12-19T06:15Z 143.6K followers, [---] engagements
"This morning we announced a U.S. supply update for the Moderna COVID-19 Vaccine reporting that [----] million doses have been supplied to the U.S. Government to date. We remain on track deliver [---] million doses to the USG by end of March [----]. Read more: https://buff.ly/39gKZVt https://buff.ly/39gKZVt"
X Link 2021-01-26T14:00Z 143.6K followers, [---] engagements
"Moderna is developing an investigational mRNA vaccine against cytomegalovirus. Learn more about #CMV here: #StopCMV #CMVawareness https://buff.ly/2UE3lI7 https://buff.ly/2UE3lI7"
X Link 2021-02-05T19:57Z 143.6K followers, [---] engagements
"We just announced two supply agreements for the COVID-19 Vaccine Moderna: one with the government of Taiwan for [--] million doses and another with the government of Colombia for [--] million doses. Read more: https://buff.ly/3p9RRZo https://buff.ly/3p9RRZo"
X Link 2021-02-09T23:19Z 143.6K followers, [----] engagements
"This evening we announced that the U.S. government has purchased an additional [---] million doses of Modernas COVID-19 Vaccine bringing its confirmed order commitment to [---] million doses. https://buff.ly/3qdvpQh https://buff.ly/3qdvpQh"
X Link 2021-02-11T22:35Z 143.6K followers, [---] engagements
"We also announced that we have increased our [----] base plan to [---] million doses and we working to supply up to [--] billion doses in [----]. Read more: https://buff.ly/3aSgF4h https://buff.ly/3aSgF4h"
X Link 2021-02-24T23:32Z 143.6K followers, [---] engagements
"We just announced that the first participants have been dosed in the Phase 2/3 study called the KidCOVE study of mRNA-1273 our vaccine candidate against COVID-19 in children ages [--] months to less than [--] years. Read more: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participants-dosed-phase-23-study-0 https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participants-dosed-phase-23-study-0"
X Link 2021-03-16T11:04Z 143.6K followers, [----] engagements
"This evening we are highlighting the publication of antibody persistence data out to [--] months following the second dose of the Moderna COVID-19 Vaccine in @NEJM . Read more: https://buff.ly/3wDvCjl https://buff.ly/3wDvCjl"
X Link 2021-04-07T23:30Z 143.6K followers, [---] engagements
"We just announced an agreement with Gavi the Vaccine Alliance to supply up to [---] million doses of the COVID-19 Vaccine Moderna including an initial [--] million doses to be delivered in the fourth quarter of [----]. Read more: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-supply-agreement-gavi-500-million-doses-covid https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-supply-agreement-gavi-500-million-doses-covid"
X Link 2021-05-03T10:05Z 143.6K followers, [---] engagements
"We announced a new supply agreement with Australia for [--] million doses of our COVID-19 vaccine including [--] million doses of our vaccine against the ancestral strain for in [----] & [--] million doses of our variant booster candidate for delivery in 2022: https://buff.ly/3eEfcAh https://buff.ly/3eEfcAh"
X Link 2021-05-12T12:20Z 143.6K followers, [---] engagements
"We just announced that the Phase 2/3 study of our COVID-19 vaccine in adolescents has met its primary immunogenicity endpoint. In the study no cases of COVID-19 were observed in participants who had received [--] doses of the vaccine: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-teencove-study-its-covid-19-vaccine https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-teencove-study-its-covid-19-vaccine"
X Link 2021-05-25T12:08Z 143.6K followers, [---] engagements
"Second we are already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant. First we have already tested a higher dose booster of mRNA-1273 (100 g) in healthy adults. First we have already tested a higher dose booster of mRNA-1273 (100 g) in healthy adults"
X Link 2021-11-26T20:37Z 143.6K followers, [---] engagements
"And third we are rapidly advancing a Omicron-specific booster candidate (mRNA-1273.529). Second we are already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant. Second we are already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant"
X Link 2021-11-26T20:38Z 143.6K followers, [---] engagements
"We just announced an agreement in principle with the Australian Government to build a state-of-the-art #mRNA vaccine manufacturing facility in Victoria Australia including access to our mRNA development engine. Read more: https://investors.modernatx.com/news/news-details/2021/Moderna-and-Australia-Announce-Collaboration-to-Bring-mRNA-Manufacturing-to-Australia/default.aspx https://investors.modernatx.com/news/news-details/2021/Moderna-and-Australia-Announce-Collaboration-to-Bring-mRNA-Manufacturing-to-Australia/default.aspx"
X Link 2021-12-13T23:11Z 143.6K followers, [---] engagements
"ANNOUNCEMENT 📢: We're proud to announce that the first participant has been dosed in the Phase [--] study of our Epstein-Barr Virus (#EBV) #mRNA #vaccine candidate. https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participant-Dosed-in-Phase-1-Study-of-its-mRNA-Epstein-Barr-Virus-EBV-Vaccine/default.aspx https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participant-Dosed-in-Phase-1-Study-of-its-mRNA-Epstein-Barr-Virus-EBV-Vaccine/default.aspx"
X Link 2022-01-05T12:06Z 143.6K followers, [---] engagements
"ANNOUNCEMENT 📢: Given the long-term threat demonstrated by Omicrons immune escape we are pleased to announce that the first participant has been dosed in the Phase [--] study of our #Omicron-specific #booster candidate (mRNA-1273.529) Learn more: https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participant-Dosed-in-Phase-2-Study-of-Omicron-Specific-Booster-Candidate-and-Publication-of-Data-on-Booster-Durability-Against-Omicron-Variant/default.aspx"
X Link 2022-01-26T22:25Z 143.6K followers, [---] engagements
"ANNOUNCEMENT 📢: We are proud to announce that the first participant has been dosed in the Phase [--] study of mRNA-1574 our experimental human immunodeficiency virus (#HIV) trimer #mRNA #vaccine candidate. https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participant-Dosed-in-Phase-1-Study-of-its-HIV-Trimer-mRNA-Vaccine/default.aspx https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participant-Dosed-in-Phase-1-Study-of-its-HIV-Trimer-mRNA-Vaccine/default.aspx"
X Link 2022-03-14T13:22Z 143.6K followers, [---] engagements
"We're announcing positive interim data from the Phase 2/3 KidCOVE study of our #COVID19 vaccine (mRNA-1273) in children [--] months to under [--] years and [--] years to under [--] years of age. https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-its-COVID-19-Vaccine-Phase-23-Study-in-Children-6-Months-to-Under-6-Years-Has-Successfully-Met-Its-Primary-Endpoint/default.aspx https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-its-COVID-19-Vaccine-Phase-23-Study-in-Children-6-Months-to-Under-6-Years-Has-Successfully-Met-Its-Primary-Endpoint/default.aspx"
X Link 2022-03-23T12:08Z 143.6K followers, [----] engagements
"We're announcing that we have submitted a request for #EUA for our #COVID19 vaccine (mRNA-1273) in children [--] months to under [--] years and [--] years to under [--] years of age to the U.S. FDA and that similar requests are underway with international regulatory authorities"
X Link 2022-04-28T11:18Z 143.6K followers, [----] engagements
"ANNOUNCEMENT 📢: A [--] g booster dose of our Omicron-containing bivalent #COVID19 #booster candidate mRNA-1273.214 demonstrated superior antibody response against the #Omicron variant one month after administration when compared to the original mRNA-1273 vaccine. Learn more 👇🏼"
X Link 2022-06-08T11:11Z 143.6K followers, [----] engagements
"We have completed our submission to the U.S. FDA for emergency use authorization for our BA.4/BA.5 #Omicron-targeting #bivalent #COVID19 booster #vaccine mRNA-1273.222. Read more: https://investors.modernatx.com/news/news-details/2022/Moderna-Completes-Application-To-U.S.-Food-And-Drug-Administration-For-Emergency-Use-Authorization-Of-Omicron-Targeting-Bivalent-Covid-19-Booster-Vaccine-mRNA-1273.222/default.aspx"
X Link 2022-08-23T20:09Z 143.6K followers, [---] engagements
"We announced today clinical trial data for our updated COVID-19 vaccine candidate in humans against BA.2.86 (Pirola) a variant under monitoring. Read more"
X Link 2023-09-06T11:07Z 143.6K followers, 397.3K engagements
"We just announced that we have submitted an IND application to the U.S. FDA for a Phase [--] study of our mRNA Vaccine (mRNA-1273) against novel coronavirus. Read more: https://buff.ly/3aIW7rq https://buff.ly/3aIW7rq"
X Link 2020-04-27T20:35Z 143.6K followers, [---] engagements
"Summary of our SARS-CoV-2 #vaccine (mRNA-1273) interim Phase [--] data. Read more: #mRNA https://buff.ly/3bEUhZ9 https://buff.ly/3bEUhZ9"
X Link 2020-05-18T12:45Z 143.6K followers, [----] engagements
"We just announced that the first participants in each age cohort have been dosed in the Phase [--] study of our mRNA vaccine (mRNA-1273) against novel coronavirus. Read more: #mRNA https://buff.ly/2XClPJS https://buff.ly/2XClPJS"
X Link 2020-05-29T21:05Z 143.6K followers, [---] engagements
"We just announced interim results from the NIH-led Phase [--] Study of our #mRNA #vaccine against COVID-19 (mRNA-1273) in @NEJM. Read more: https://buff.ly/2WjGoLr https://buff.ly/2WjGoLr"
X Link 2020-07-14T21:21Z 143.6K followers, [----] engagements
"Read more in our press release here: https://buff.ly/2WjGoLr https://buff.ly/2WjGoLr"
X Link 2020-07-14T22:05Z 143.6K followers, [----] engagements
"We just announced an expansion of our agreement with @BARDA for up to an additional $472 million to support our late stage clinical development of mRNA-1273 including the execution of a [-----] participant Phase [--] study in the U.S. Read more: https://buff.ly/32XjxZV https://buff.ly/32XjxZV"
X Link 2020-07-26T14:25Z 143.6K followers, [----] engagements
"To provide additional transparency in context of pandemic the protocol for the Phase [--] COVE study of mRNA-1273 being conducted in collaboration with the NIH and BARDA is now available: #mRNA https://buff.ly/32Ea6OL https://buff.ly/32Ea6OL"
X Link 2020-09-17T11:12Z 143.6K followers, [---] engagements
"We just announced that we have received confirmation of eligibility for submission of a Marketing Authorization Application to the European Medicines Agency for mRNA-1273 https://buff.ly/3lPeqBd https://buff.ly/3lPeqBd"
X Link 2020-10-14T12:05Z 143.6K followers, [---] engagements
"We just announced that we have completed enrollment of [-----] participants for the Phase [--] COVE study of mRNA-1273 our vaccine candidate against COVID-19. Read more: https://buff.ly/3oilbh2 https://buff.ly/3oilbh2"
X Link 2020-10-22T13:52Z 143.6K followers, [---] engagements
"We just announced a longer shelf life at refrigerated temperatures for mRNA-1273 our COVID-19 vaccine candidate. Read more: https://buff.ly/3f2RE6V https://buff.ly/3f2RE6V"
X Link 2020-11-16T11:55Z 143.6K followers, [----] engagements
"Moderna confirms advanced discussions with the European Commission to purchase an initial [--] million doses of mRNA-1273 with the option to purchase up to an additional [--] million doses"
X Link 2020-11-24T14:51Z 143.6K followers, [---] engagements
"We just announced the primary efficacy analysis in the Phase [--] COVE study for mRNA-1273 our COVID-19 vaccine candidate and that today we plan to request an Emergency Use Authorization from the U.S. FDA & conditional approval from the EMA. Read more: https://buff.ly/2Jt56Fz https://buff.ly/2Jt56Fz"
X Link 2020-11-30T12:04Z 143.6K followers, [----] engagements
"We just announced that the FDA has authorized the Moderna COVID-19 Vaccine in the U.S. for emergency use to prevent COVID-19 in individuals [--] and over. The Moderna COVID-19 Vaccine has not been approved or licensed by the FDA. https://buff.ly/34oHMjW https://buff.ly/34oHMjW"
X Link 2020-12-19T00:59Z 143.6K followers, [----] engagements
"We just announced that Health Canada has authorized the Moderna COVID-19 Vaccine in Canada. Read more: https://buff.ly/3rrsvIL https://buff.ly/3rrsvIL"
X Link 2020-12-23T16:43Z 143.6K followers, [---] engagements
"We just confirmed that the Company is engaged in discussions with the government of South Korea to potentially provide [--] million or more doses of the Moderna COVID-19 Vaccine. Read more: https://buff.ly/3hq48Xk https://buff.ly/3hq48Xk"
X Link 2020-12-29T21:12Z 143.6K followers, [---] engagements
"We just announced that Israels Ministry of Health (MOH) has given authorization to import the COVID-19 Vaccine Moderna in Israel. Read more here: https://buff.ly/2LiOeSH https://buff.ly/2LiOeSH"
X Link 2021-01-05T00:56Z 143.6K followers, [---] engagements
"We just announced that the UKs MHRA has approved our mRNA vaccine against COVID-19 for use. The UK government also secured an additional [--] million doses of the COVID-19 Vaccine Moderna. Read more: https://buff.ly/3omOnDg https://buff.ly/3omOnDg"
X Link 2021-01-08T12:52Z 143.6K followers, [---] engagements
"We just announced that the Moderna COVID-19 Vaccine retains neutralizing activity against emerging variants first identified in the U.K. and the Republic of South Africa. Read more: https://buff.ly/39i2cOp https://buff.ly/39i2cOp"
X Link 2021-01-25T13:39Z 143.6K followers, 27.4K engagements
"Now available as a preprint on bioRxiv: mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. Read more here: https://buff.ly/3phX7eq https://buff.ly/3phX7eq"
X Link 2021-01-25T16:26Z 143.6K followers, [---] engagements
"We just announced a supply update for the Moderna COVID-19 Vaccine in the United States reporting that [----] million doses have been supplied to the U.S. Government to date. Read more: https://buff.ly/3dhNpFG https://buff.ly/3dhNpFG"
X Link 2021-02-16T14:07Z 143.6K followers, [----] engagements
"Earlier today we announced that we shipped our variant-specific vaccine candidate mRNA-1273.351 to the @NIH for a Phase [--] clinical trial that will be led and funded by the NIHs National Institute of Allergy and Infectious Diseases (NIAID). Read more: https://buff.ly/3uFcZLc https://buff.ly/3uFcZLc"
X Link 2021-02-24T23:27Z 143.6K followers, [---] engagements
"We just announced that the first participants have been dosed with our modified COVID-19 vaccines designed to address the potential need for booster vaccine candidates in an amendment to the ongoing Phase [--] clinical study. Read more: https://buff.ly/38t7DZO https://buff.ly/38t7DZO"
X Link 2021-03-10T21:17Z 143.6K followers, [----] engagements
"We just announced that the Philippines has secured [--] million additional doses of our COVID-19 vaccine through a new supply agreement & partnership with the private sector bringing its confirmed order commitment to [--] million doses. Read more: https://buff.ly/3f4hzgs https://buff.ly/3f4hzgs"
X Link 2021-03-22T14:02Z 143.6K followers, [----] engagements
"100 days after receiving Emergency Use Authorization from the U.S. FDA we are proud to share that weve shipped the 100-millionth dose of our COVID-19 vaccine to the U.S. Government. Read more: https://buff.ly/3wjcg38 https://buff.ly/3wjcg38"
X Link 2021-03-29T12:08Z 143.6K followers, [---] engagements
"Moderna's statement on CVST or thrombotic events"
X Link 2021-04-13T13:19Z 143.6K followers, [----] engagements
"New preclinical data shows variant-specific booster vaccine candidates (mRNA-1273.351 and mRNA-1273.211) increase neutralizing titers against SARS-CoV-2 variants of concern. Read more: https://investors.modernatx.com/news-releases/news-release-details/moderna-provides-clinical-and-supply-updates-covid-19-vaccine https://investors.modernatx.com/news-releases/news-release-details/moderna-provides-clinical-and-supply-updates-covid-19-vaccine"
X Link 2021-04-13T22:19Z 143.6K followers, [---] engagements
"Ongoing development data related to the current formulation of our COVID-19 vaccine could support a 3-month refrigerated (2-8C) shelf life for the vaccine in alternative formats to facilitate easier distribution to doctors offices & other smaller settings if authorized"
X Link 2021-04-29T10:35Z 143.6K followers, [---] engagements
"Today we are celebrating RNA Day Every day our bodies use RNA to make proteins to carry out activities like eating breathing and working. Happy #RNA Day #Science"
X Link 2021-08-01T06:50Z 143.6K followers, [---] engagements
"Today we shared positive pre-clinical data demonstrating our ability to combine [--] mRNAs against [--] different respiratory viruses in [--] vaccine: COVID-19 booster + Flu booster + RSV booster. #mRNA"
X Link 2021-09-09T14:50Z 143.6K followers, 24.4K engagements
"Respiratory viruses are a leading cause of many hospitalizations and deaths. We believe Moderna could be first to market with a COVID + Flu + RSV booster vaccine. A single vaccine to cover multiple viruses. #IDWeek2021"
X Link 2021-10-03T15:03Z 143.6K followers, [---] engagements
"Today we announced that we will build a state-of-the-art #mRNA facility in Africa to manufacture up to [---] million doses per year. Since our founding in [----] our mission has been to make a transformative impact on human lives through our medicines: https://buff.ly/3oBVNFK https://buff.ly/3oBVNFK"
X Link 2021-10-07T06:57Z 143.6K followers, [---] engagements
"We just announced our strategy to address the omicron (B.1.1.529) SARS-CoV-2 variant. Read more: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-strategy-address-omicron-b11529-sars-cov-2 https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-strategy-address-omicron-b11529-sars-cov-2"
X Link 2021-11-26T20:32Z 143.6K followers, [----] engagements
"ANNOUNCEMENT 📢: We are proud to announce that the first participant has been dosed in the Phase [--] study of mRNA-1644 our experimental #HIV #mRNA #vaccine candidate. Learn more about this exciting venture with @IAVI: https://investors.modernatx.com/news/news-details/2022/IAVI-and-Moderna-Launch-Trial-of-HIV-Vaccine-Antigens-Delivered-Through-mRNA-Technology/default.aspx https://investors.modernatx.com/news/news-details/2022/IAVI-and-Moderna-Launch-Trial-of-HIV-Vaccine-Antigens-Delivered-Through-mRNA-Technology/default.aspx"
X Link 2022-01-27T14:06Z 143.6K followers, 28.6K engagements
"A [--] g #booster dose of our first bivalent booster #vaccine candidate mRNA-1273.211 demonstrated superiority against Beta Delta and #Omicron variants of concern one month after administration and superiority continued six months after administration. https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-Clinical-Update-on-Bivalent-COVID-19-Booster-Platform/default.aspx https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-Clinical-Update-on-Bivalent-COVID-19-Booster-Platform/default.aspx"
X Link 2022-04-19T12:23Z 143.6K followers, [---] engagements
"Our Omicron-containing bivalent #booster candidate mRNA-1273.214 demonstrates significantly higher neutralizing antibody response against #Omicron subvariants BA.4/5 compared to currently authorized booster. Read more: #BA4 #BA5 https://investors.modernatx.com/news/news-details/2022/Modernas-Omicron-Containing-Bivalent-Booster-Candidate-mRNA-1273.214-Demonstrates-Significantly-Higher-Neutralizing-Antibody-Response-Against-Omicron-Subvariants-BA.45-Compared-To-Currently-Authorized-Booster/default.aspx"
X Link 2022-07-11T12:08Z 143.6K followers, [----] engagements
"We announced today that the U.S. FDA has approved mNEXSPIKE a new vaccine against COVID-19 for use in all adults [--] and older as well as individuals aged [--] years through [--] years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. Learn more: https://investors.modernatx.com/news/news-details/2025/Moderna-Receives-U-S--FDA-Approval-for-COVID-19-Vaccine-mNEXSPIKE/default.aspx https://investors.modernatx.com/news/news-details/2025/Moderna-Receives-U-S--FDA-Approval-for-COVID-19-Vaccine-mNEXSPIKE/default.aspx"
X Link 2025-05-31T05:05Z 143.6K followers, 2.9M engagements
"We just announced that the European Commission has exercised its option to purchase an additional [--] million doses of mRNA-1273 our COVID-19 vaccine candidate bringing its confirmed order commitment to [---] million doses. Read more: https://buff.ly/38eVXZY https://buff.ly/38eVXZY"
X Link 2020-12-18T13:13Z 143.6K followers, [---] engagements
"We just announced that we have shipped vials of mRNA-1273 the Companys vaccine against the novel coronavirus to the NIH to be used in the planned Phase [--] study in the U.S. https://investors.modernatx.com/news-releases/news-release-details/moderna-ships-mrna-vaccine-against-novel-coronavirus-mrna-1273 https://investors.modernatx.com/news-releases/news-release-details/moderna-ships-mrna-vaccine-against-novel-coronavirus-mrna-1273"
X Link 2020-02-24T23:25Z 143.6K followers, [----] engagements
"We just announced that the first participant has been dosed in the NIH-led Phase [--] study of our #mRNA vaccine (mRNA-1273) against novel coronavirus https://buff.ly/33nqi5v https://buff.ly/33nqi5v"
X Link 2020-03-16T17:09Z 143.6K followers, [----] engagements
"We are pleased to share a preprint of the preclinical manuscript for our #vaccine against #SARS-CoV-2 to potentially prevent #COVID19 disease. We thank the NIAID team for their collaboration with our infectious disease research team. @NIAIDNews https://buff.ly/2N4dvhj https://buff.ly/2N4dvhj"
X Link 2020-06-12T12:42Z 143.6K followers, [---] engagements
"July [--] statement from Moderna"
X Link 2020-07-02T17:51Z 143.6K followers, [---] engagements
"We just announced that the Phase [--] study of mRNA-1273 our vaccine candidate against COVID-19 has begun. The Phase [--] study being conducted in collaboration with @NIH and @BARDA. Read more here: https://buff.ly/2EfWQWC https://buff.ly/2EfWQWC"
X Link 2020-07-27T10:56Z 143.6K followers, [----] engagements
"Breaking: Moderna announces a supply agreement with the U.S. government to secure an initial [---] million doses of mRNA-1273 for up to $1.525 billion with option granted to U.S. government to purchase up to an additional [---] million doses"
X Link 2020-08-11T21:45Z 143.6K followers, [----] engagements
"We just announced that we have concluded advanced exploratory talks with the European Commission to supply [--] million doses of mRNA-1273. Read more here: https://buff.ly/3jamCuy https://buff.ly/3jamCuy"
X Link 2020-08-24T13:22Z 143.6K followers, [---] engagements
"Update: Modernas data for the Emergency Use Authorization request for mRNA-1273 has been submitted to the U.S. FDA"
X Link 2020-11-30T21:57Z 143.6K followers, [----] engagements
"Update: The European Medicines Agency has received Modernas application for conditional marketing authorization of our COVID-19 vaccine"
X Link 2020-12-01T14:14Z 143.6K followers, [---] engagements
"We just provided an update on mRNA-1273 our COVID-19 vaccine candidate including interim durability data from the NIH-led Phase [--] study of mRNA-1273 and a production update. Read more: https://buff.ly/3gaQDue https://buff.ly/3gaQDue"
X Link 2020-12-03T22:17Z 143.6K followers, [---] engagements
"This morning we announced that the Canadian government has increased its confirmed order commitment by [--] million doses of mRNA-1273 our vaccine candidate against COVID-19 bringing its confirmed order commitment to [--] million doses. Read more: https://buff.ly/3qxDsYW https://buff.ly/3qxDsYW"
X Link 2020-12-07T15:09Z 143.6K followers, [---] engagements
"Modernas statement on variants of the SARS-CoV-2 virus: https://investors.modernatx.com/news-releases/news-release-details/statement-variants-sars-cov-2-virus https://investors.modernatx.com/news-releases/news-release-details/statement-variants-sars-cov-2-virus"
X Link 2020-12-24T01:15Z 143.6K followers, [---] engagements
"We also announced that out of an abundance of caution we are launching a clinical program to boost immunity to emerging variants. Learn more: https://buff.ly/39i2cOp https://buff.ly/39i2cOp"
X Link 2021-01-25T13:41Z 143.6K followers, [---] engagements
"We just announced that the first participants have been dosed in the Phase [--] study of mRNA-1283 our next generation COVID-19 vaccine candidate. Read more: https://buff.ly/3li2YPw https://buff.ly/3li2YPw"
X Link 2021-03-15T13:35Z 143.6K followers, [---] engagements
"We are grateful for the opportunity to present the clinical data package for our COVID-19 booster vaccine to the FDAs advisory committee today. We thank the committee for their review & for their unanimous vote in support of EUA of the [--] g booster dose"
X Link 2021-10-14T19:25Z 143.6K followers, [---] engagements
"None of this would be possible without our partnerships and we are grateful to @gatesfoundation @scrippsresearch @UTSA @GWtweets @fredhutch and @EmoryUniversity"
X Link 2022-01-27T14:06Z 143.6K followers, [----] engagements
"BREAKING: The @FDA has approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine mRNA) to prevent #COVID19 in individuals [--] years of age and older"
X Link 2022-01-31T16:07Z 143.6K followers, [----] engagements
"What if #mRNA could treat life-threatening #cardiovascular diseases such as #HeartFailure We are collaborating with @AstraZeneca on an mRNA therapeutic (AZD8601) that encodes for VEGF-A to promote recovery of cardiac function through tissue regeneration. https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-data-phase-2-study-mrna-vegf https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-data-phase-2-study-mrna-vegf"
X Link 2022-02-09T14:52Z 143.6K followers, [----] engagements
"We're announcing that with the assistance of the U.S. Government we have entered into a Memorandum of Understanding with the Government of the Republic of Kenya to establish #Kenya as the location for the our #mRNA manufacturing facility. https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-Memorandum-of-Understanding-with-the-Government-of-the-Republic-of-Kenya-to-Establish-its-First-mRNA-Manufacturing-Facility-in-Africa/default.aspx"
X Link 2022-03-07T13:30Z 143.6K followers, [----] engagements
"ANNOUNCEMENT 📢: The first participant has been dosed in a Phase 2/3 trial of mRNA-1273.222 a bivalent #COVID19 #booster vaccine candidate targeting the original and #Omicron BA.4/5 strains of SARS-CoV-2"
X Link 2022-08-11T15:00Z 143.6K followers, [---] engagements
"Today we announced that Phase [--] data on mRNA-4156/V940 our investigational personalized #mRNA #cancer vaccine will be presented at the [----] American Association of Cancer Research Annual Meeting being held April 14-19 in Orlando FL. mRNA-4157/V940 is being jointly developed by Moderna and @Merck known as MSD outside of the United States and Canada. Read more: #AACR23 https://investors.modernatx.com/news/news-details/2023/Moderna-Announces-Phase-2-Data-on-mRNA-4157V940-an-Investigational-mRNA-Personalized-Cancer-Vaccine-to-be-Presented-at-the-2023-AACR-Annual-Meeting/default.aspx"
X Link 2023-03-14T23:02Z 143.6K followers, 97.5K engagements
"Your risk of #LongCOVID rises with each additional infection. A recent study has shown that by their third COVID infection patients have a 40% chance of developing Long COVID symptoms. Learn more about the threat of Long COVID: https://www.modernatx.com/en-US/media-center/all-media/blogs/long-covid-awareness-day-2024 https://www.modernatx.com/en-US/media-center/all-media/blogs/long-covid-awareness-day-2024"
X Link 2024-05-06T17:31Z 143.6K followers, 2.1M engagements
"Were excited to announce the launch of our new awareness campaign Do It For You & Them. This initiative is part of our broader efforts to educate the public about the ongoing risks of COVID-19 and its continued impact on daily life. With COVID-19 infection rates still elevated across the country staying up to date on your COVID-19 vaccination is one of the best ways to protect yourself and your loved ones. Updated vaccines are now available find one near you today: http://ForYouAndThem.com http://ForYouAndThem.com"
X Link 2024-08-29T12:30Z 143.6K followers, 94.3K engagements
"Today we are sharing an important update about our protocol for the Phase [--] COVE Study of mRNA-1273 our vaccine candidate against COVID-19"
X Link 2020-08-05T17:01Z 143.6K followers, [---] engagements
"Earlier today we announced a supply agreement to provide [--] million doses of COVID-19 Vaccine Moderna to the Philippines. Read more: https://buff.ly/2MQUdzc https://buff.ly/2MQUdzc"
X Link 2021-03-06T21:48Z 143.6K followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing